Ralf Clemens

Grid Europe Consult

SCHOLARLY PAPERS

2

DOWNLOADS

977

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Randomized Immunogenicity and Safety Study of Heterologous Versus Homologous COVID-19 Booster Vaccination in Previous Recipients of Two Doses Of Coronavac COVID-19 Vaccine

Number of pages: 32 Posted: 30 Dec 2021
University of Siena - Institute of Global Health, Federal University of Sao Paulo, Grid Europe Consult, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine and affiliation not provided to SSRN
Downloads 972 (33,072)

Abstract:

Loading...

Randomized, Immunogenicity, Safety, study, heterologous, homologous, COVID-19, booster, vaccination, two dose, three dose, third, second, Coronavac, Sinovac, SARS-CoV-2, schedule, coronavirus, pandemic, Oxford, Brazil, Ministry of Health, protection

2.

COVID-19 Site Readiness Initiative: Building Clinical Trial Capacity for Vaccine Efficacy Trials in Latin America in Response to the Pandemic

JVACX-D-22-00042
Number of pages: 33 Posted: 18 May 2022
University of Siena - Head of the Institute for Global Health,, Takeda Pharmaceuticals, Instituto D’Or de pesquisa e ensino and Grid Europe Consult
Downloads 5 (826,853)

Abstract:

Loading...

Capacity building, Clinical trial, Clinical trial site, COVID-19, Latin America, Vaccine trial.